Literature DB >> 11549265

Oxidation of melatonin and tryptophan by an HRP cycle involving compound III.

V F Ximenes1, L H Catalani, A Campa.   

Abstract

We recently described that horseradish peroxidase (HRP) and myeloperoxidase (MPO) catalyze the oxidation of melatonin, forming the respective indole ring-opening product N(1)-acetyl-N(2)-formyl-5-methoxykynuramine (AFMK) (Biochem. Biophys. Res. Commun. 279, 657-662, 2001). Although the classic peroxidatic enzyme cycle is expected to participate in the oxidation of melatonin, the requirement of a low HRP:H(2)O(2) ratio suggested that other enzyme paths might also be operative. Here we followed the formation of AFMK under two experimental conditions: predominance of HRP compounds I and II or presence of compound III. Although the consumption of substrate is comparable under both conditions, AFMK is formed in significant amounts only when compound III predominates during the reaction. Using tryptophan as substrate, N- formyl-kynurenine is formed in the presence of compound III. Both, melatonin and tryptophan efficiently prevents the formation of p-670, the inactive form of HRP. Since superoxide dismutase (SOD) inhibits the production of AFMK, we proposed that compound III acts as a source of O(-*)(2) or participates directly in the reaction, as in the case of enzyme indoleamine 2,3-dioxygenase. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549265     DOI: 10.1006/bbrc.2001.5557

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Reaction of N-hydroxyguanidine with the ferrous-oxy state of a heme peroxidase cavity mutant: a model for the reactions of nitric oxide synthase.

Authors:  Alycen Pond Nigro; David B Goodin
Journal:  Arch Biochem Biophys       Date:  2010-03-25       Impact factor: 4.013

2.  Melatonin inhibits nitric oxide production by microvascular endothelial cells in vivo and in vitro.

Authors:  C L M Silva; E K Tamura; S M D Macedo; E Cecon; L Bueno-Alves; S H P Farsky; Z S Ferreira; R P Markus
Journal:  Br J Pharmacol       Date:  2007-03-20       Impact factor: 8.739

3.  The nature of heme/iron-induced protein tyrosine nitration.

Authors:  Ka Bian; Zhonghong Gao; Norman Weisbrodt; Ferid Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-22       Impact factor: 11.205

4.  Indole peroxygenase activity of indoleamine 2,3-dioxygenase.

Authors:  Hsin H Kuo; A Grant Mauk
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

5.  Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan: investigations with both indoleamine 2,3-dioxygenase and myeloperoxidase.

Authors:  Gilles Ferry; Caroline Ubeaud; Pierre-Hervé Lambert; Sophie Bertin; Francis Cogé; Pascale Chomarat; Philippe Delagrange; Bernard Serkiz; Jean-Paul Bouchet; Roger J W Truscott; Jean A Boutin
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

6.  A model of the oscillatory metabolism of activated neutrophils.

Authors:  Lars F Olsen; Ursula Kummer; Andrei L Kindzelskii; Howard R Petty
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

7.  Melatonin metabolism in the central nervous system.

Authors:  Rüdiger Hardeland
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

8.  Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug.

Authors:  Rüdiger Hardeland; S R Pandi-Perumal
Journal:  Nutr Metab (Lond)       Date:  2005-09-10       Impact factor: 4.169

9.  A Testosterone Metabolite 19-Hydroxyandrostenedione Induces Neuroendocrine Trans-Differentiation of Prostate Cancer Cells via an Ectopic Olfactory Receptor.

Authors:  Tatjana Abaffy; James R Bain; Michael J Muehlbauer; Ivan Spasojevic; Shweta Lodha; Elisa Bruguera; Sara K O'Neal; So Young Kim; Hiroaki Matsunami
Journal:  Front Oncol       Date:  2018-05-28       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.